Glenmark's anti-diabetic drug biosimilar claims to cut therapy cost by 70%
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
